Skip to main content
E11 Bio logo

E11 Bio

Alameda, California, United StatesSee on the mapFounded 2021

  • Neuroimaging
  • Neuroscience research tools

E11 Bio is a focused research organization building scalable, single-cell brain circuit mapping capabilities. Its work combines advanced microscopy, sample preparation, and computational methods to produce and analyze large-scale connectomics data for neuroscience research.

Open roles
5
Posted last 30 days
5
Raised
$50M
Investors
3
Founded
2021

reccy insights

Recent highlights

E11 Bio was founded in 2021 and is based in Alameda, California. Its clearest dated financial milestone is a $50 million joint funding commitment announced in March 2022, with Schmidt Futures and Ken Griffin listed as lead investors. A separate grant is associated with the Alfred P. The company’s stated research focus is making single-cell brain circuit mapping more accessible to neuroscience researchers, with work spanning experimental methods and computational analysis. Its described technical approaches include optical connectomics, expansion microscopy, large-scale light microscopy, and machine-learning-assisted proofreading of neuron and synapse reconstructions. The company has a reported headcount of 27, within an employee range of 11–50. The funding commitment is a historical milestone, not a recent announcement.

Written by reccy's AI from company sites, press and funding records · updated Nov 2026

Open roles5

5 roles posted in the last 30 days

  1. 0Jun
  2. 0Jul
  3. 0Aug
  4. 0Sep
  5. 1Oct
  6. 4Nov

What makes E11 Bio distinct

  1. 01Focuses on scaling brain circuit mapping to the single-cell level.
  2. 02Combines wet-lab research, advanced imaging, and computational science.
  3. 03Develops automated proofreading methods for neuron and synapse reconstructions.
  4. 04Builds workflows intended to improve brain-mapping data quality, reproducibility, and throughput.

Technology & products

  • Optical connectomics workflows
  • Expansion microscopy
  • Light microscopy workflows for large-scale image acquisition
  • Barcode- and shape-informed machine-learning methods for proofreading neuron and synapse reconstructions
  • Large-scale brain-mapping data processing pipelines

Funding

$50M disclosed
  • Joint Funding CommitmentMar 2022
    $50MLed by Schmidt Futures, Ken Griffin
  • Grant
    Alfred P. Sloan Foundation
3 investors

Similar companies

About E11 Bio

Leadership
Andrew PayneTodd HuffmanJohan WinnubstJun Penman
Focus areas
Neuroscience, brain mapping, connectomics, biotechnology, research tools, microscopy, machine learning, scientific computing
Headquarters
Alameda, California, United States
Founded
2021
Employees
11–50